[DOI] [PMC free article] [PubMed] [Google Scholar] 54.Atzeni F., Casale R., Alciati A., et al
No, they cant
This dual mechanismrapid weight loss combined with potential direct effects on gallbladder functionmay explain the observed association between GLP-1 therapy and gallstone risk
When usedin vivo, GSSG will not remain oxidized, but rather be reduced back to GSH
Before requesting a dose change, discuss with your provider whether your current dose aligns with your weight loss goals and timeline
Several important safety considerations from the SmPC should be noted: If pancreatitis is suspected, Ozempic should be discontinued immediately and urgent medical assessment sought Patients should be counselled about gallbladder disease symptoms, as GLP-1 receptor agonists may increase the risk of gallstones [14] Those with pre-existing diabetic retinopathy should be monitored for potential worsening, particularly during rapid improvement in glucose control If a patient is taking warfarin or other coumarin derivatives, more frequent INR monitoring is recommended when starting Ozempic [1] Before initiating Ozempic in patients with known liver conditions, healthcare professionals should conduct a thorough assessment of liver disease severity, review concurrent medications for potential interactions, and establish baseline liver function tests
